


The Fund aims to provide long term total returns primarily through investment in the shares of companies around the world. Investments will largely be determined by the application of a contrarian investment process and will be in a selection of companies which will not be restricted either by size, industry, or geographical location.
| Name | % Net Assets |
|---|---|
| Pfizer Inc. | 2.4% |
| Medtronic Inc. | 2.4% |
| Lagardere Groupe | 2.3% |
| SK Telecom Co. | 2.2% |
| Glaxosmithkline | 2.1% |
| NTT Docomo Inc. | 2.1% |
| Yamaha Corp | 2.1% |
| Helical Bar Plc | 1.9% |
| ENI S.P.A. | 1.9% |
| Merck & Co Inc. | 1.8% |
| Key | % Net Assets |
|---|---|
| 2.4% | |
| 2.4% | |
| 2.3% | |
| 2.2% | |
| 90.7% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 341.11p |
| Currency | GBP |
| Change | -1.63p |
| % | -0.48% |
| YTD change | 39.10p |
| YTD % | 12.95% |
| Fund Inception | 17/12/2007 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research